praxair8k_020215.htm      

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549 

———————————— 

FORM 8-K 

CURRENT REPORT 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 

Date of Report (Date of earliest event reported): February 2, 2015 (January 29, 2015) 

———————————— 

PRAXAIR, INC. 

(Exact name of registrant as specified in its charter) 

———————————— 

 [DATA_TABLE_REMOVED]  

39 Old Ridgebury Road 

Danbury, CT 06810-5113 

(Address of principal executive offices) 

(203) 837-2000 

(Registrant’s telephone number, including area code) 

Not Applicable 

(Former name or former address, if changed since last report) 

———————————— 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

Item 1.01. Entry into a Material Definitive Agreement. 

On January 29, 2015, Praxair, Inc. (the “Company”) priced $150,000,000 aggregate principal amount of floating rate notes due February 3, 2017 (the “Floating Rate Notes”), $400,000,000 aggregate principal amount of 2.650% notes due February 5, 2025 (the “2025 Notes”) and $200,000,000 aggregate principal amount of 3.550% notes due November 7, 2042 (the “2042 Notes” and, together with the Floating Rate Notes and the 2025 Notes, the “Notes”). The 2042 Notes will be of the same series as the $475,000,000 of 3.550% Notes due 2042 that the Company issued on November 7, 2012 and May 7, 2013. The Notes will be sold on February 5, 2015 in a registered offering under the Securities Act of 1933, pursuant to the Company’s shelf registration statement on Form S-3 filed with the Securities and Exchange Commission (“SEC”) on August 8, 2012. The material terms of the Notes are described in the Company’s prospectus supplement dated January 29, 2015 filed with the SEC on February 2, 2015. 

In connection with the pricing of the Notes, the Company entered into a Terms Agreement dated January 29, 2015 (the “Terms Agreement”) with Credit Suisse Securities (USA) LLC, J.P. Morgan Securities LLC, RBS Securities Inc. and Wells Fargo Securities, LLC, as representatives of the underwriters named therein (the “Underwriters”). Pursuant to and subject to the terms and conditions of the Terms Agreement, the Underwriters agreed to purchase the Notes from the Company for resale in the registered offering. The Terms Agreement is filed as Exhibit 1 to this Form 8-K. 

Item 9.01. Financial Statements and Exhibits. 

(d)   Exhibits. The following exhibits are filed herewith: 

  Exhibit No.   

Description 

1 

Terms Agreement dated January 29, 2015 

SIGNATURES 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

Dated: February 2, 2015 

 [DATA_TABLE_REMOVED]  

Exhibit Index 

   Exhibit No. Description 

  1    Terms Agreement dated January 29, 2015